CL

CL

USD

Colgate-Palmolive Company Common Stock

$76.550+0.750 (0.989%)

Reaalajas hind

Consumer Defensive
Household & Personal Products
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$75.800

Kõrge

$76.585

Madal

$75.000

Maht

6.40M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

61.7B

Tööstusharu

Household & Personal Products

Riik

United States

Kauplemisstatistika

Keskmine maht

5.80M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $74.55Praegune $76.550Kõrge $100.18

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 2. nov 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

Colgate-Palmolive (CL): Mixed Signals Near Key Support Level

Company Overview

Colgate-Palmolive (CL), a leader in household and personal care products, operates with 34,000 employees across categories like oral hygiene, pet nutrition, and home care. Its current stock price ($76.51) sits near a 52-week low ($74.62), with a market cap of $62.3B and a P/E ratio of 19.96. The company recently cut its annual sales forecast, citing weak consumer demand, after reporting Q3 revenue growth of 1.9%--below analyst expectations.


Price Action Review

Over the past three months:

  • Trend: Bearish. Shares dropped 10.8% from $85.78 (Aug 20) to $76.51 (Oct 31).
  • Volatility: Low (avg volume: 5.7M shares), though sudden sell-offs occurred in late October (e.g., $79.86 → $77.14 in 3 days).
  • Key Levels:
  • Support: $76.37 (Bollinger Band lower bound).
  • Resistance: $85.43 (Oct 20 high) and $88.84 (analyst price target).

Technical indicators suggest a bullish breakout is possible if prices hold above $74.95 (stop-loss level). The MACD golden cross and surging On-Balance Volume (15.4x average) hint at short-term buying pressure.


News Sentiment Analysis

Recent headlines show conflicting signals:

  • Negative: CL lowered its annual sales forecast on Oct 31, citing "rising economic uncertainty" impacting demand for premium-priced products--even in essentials like toothpaste.
  • Neutral: Q3 organic sales rose just 0.4%, dragged down by a "non-strategic exit from private-label pet sales."
  • Positive: JP Morgan reiterated an "Overweight" rating on Oct 10, though cutting its price target from $95 to $88.

Analyst sentiment remains optimistic

Seotud uudised

Analyst Upgrades

Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive with a Equal-Weight and lowers the price target from $82 to $80.

Vaata rohkem
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
Reuters

Procter & Gamble can be sued over Kid's Crest packaging, US judge rules

Procter & Gamble must face a lawsuit alleging that its packaging for Kid's Crest suggests that children can use more of the toothpaste than is safe.

Vaata rohkem
Procter & Gamble can be sued over Kid's Crest packaging, US judge rules
Analyst Upgrades

UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90

UBS analyst Peter Grom maintains Colgate-Palmolive with a Buy and lowers the price target from $92 to $90.

Vaata rohkem
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
Analyst Upgrades

Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive with a Buy and lowers the price target from $105 to $95.

Vaata rohkem
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
Analyst Upgrades

Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive with a Overweight and lowers the price target from $96 to $87.

Vaata rohkem
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
Analyst Upgrades

JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive with a Overweight and lowers the price target from $88 to $87.

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94

Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive with a Outperform and lowers the price target from $100 to $94.

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Langev

Uuendatud kell: 5. nov 2025, 07:26

LangevNeutraalneTõusev

64.8% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Konservatiivne
Kauplemisjuhend

Sisenemispunkt

$76.25

Võta kasum

$78.60

Peata kahjum

$74.86

Põhitegurid

PDI 10.5 on MDI 4.8 kohal ADX-iga 24.3, mis viitab tõusutrendile
Praegune hind on tugitasemele ($76.37) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 13.4x keskmisest (70,707), mis viitab äärmiselt tugevale ostusurvele
MACD 0.2771 on signaalijoone 0.2137 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.